Global Counterfeit Drug Detection Device By Product (Counterfeit Chemical Composition Detection Devices, Counterfeit Packaging & Labelling Detection Devices), Modality (Portable Devices, Handheld Devices, Benchtop Devices), End Use (Pharmaceutical Companies, Drug Testing Laboratories, Research Organizations, Others), Drug Assessment (Oral Pill, Injectable, Inhalable, Topical, Eye Drop), Therapeutic Assessment (Alimentary, Anti-Infectives, Blood Agents, Cardiovascular, Central Nervous System, Cytostatics, Dermatological, Genitourinary, Hormones, Hospital Solutions, Metabolism, Musculoskeletal, Respiratory, Other Parasitology, and Sensory Organs), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Share Forecast to 2027
Market Analysis and Insights: Global Counterfeit Drug Detection Device Market
Counterfeit drug detection device market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 1.68 billion by 2027 growing at a CAGR of 4.30% in the above-mentioned forecast period. The growing awareness amongst healthcare and pharmaceuticals industry to restrict the usage of fake medicines and packaging adulteration has been directly impacting the growth of counterfeit drug detection device market.
Counterfeit drug is the biggest problem faced by healthcare world, the tools and devices for the detection of duplicate medics owing to the technological advancements is expected to enhance the market growth in the anticipated time period. The holographic duplicity is the biggest challenge faced by pharma packaging industry, government initiatives to lower down such practices with the help of public and private enterprises is adding a thrust in the strategic business growth of counterfeit drug detection device market across the globe. Emphasize on advanced surveillance on the supply and chain industry of drugs is catering vertical uplift of success, both in terms of revenues and shares. Best churned out way to limit fake medicines and drugs is the new invented methodology of one- dose technology, this is the most effective way to restore the authenticity of product, and this trending practice is helping the counterfeit drug detection device market to grow. Certain mentioned attributes are components driving the market growth of counterfeit drug detection device in the forecasted period of 2020 to 2027.
In the projected period of market surge counterfeit drug detection device market is vulnerable to restraints as well. The production of fake medicines in Myanmar region and some unwanted terrorist organization can hamper the market growth. Loop holes in the hierarchy of packaging industry and sublimation of product while transportation also curbs the market growth of counterfeit drug detection device.
This counterfeit drug detection device market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on counterfeit drug detection device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Counterfeit Drug Detection Device Market and Market Size
Counterfeit drug detection device market is segmented on the basis of product, modality, drug assessment, therapeutic assessment and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the counterfeit drug detection device market is segmented into chemical composition detection devices, and packaging & labelling detection devices. Counterfeit chemical composition detection devices are further divided into ultraviolet/vis devices, infrared and near infrared spectroscopy devices, Raman spectrometers, and XRD & XRF spectroscopy devices. Counterfeit packaging & labelling detection devices is further sub-segmented into RFID analyzers, scanning and imaging systems, and others.
- On the basis of modality, the counterfeit drug detection device market is bifurcated into portable devices, handheld devices, and benchtop devices.
- On the basis of end use,, the counterfeit drug detection device market is segregated into pharmaceutical companies, drug testing laboratories, and research organizations.
- On the basis of drug assessment, the counterfeit drug detection device market is segmented into oral pill, injectable, inhalable, topical, and eye drop.
- On the basis of therapeutic assessment, the counterfeit drug detection device market is fragmented into alimentary, anti-infectives, blood agents, cardiovascular, central nervous system, cytostatics, dermatological, genitourinary, hormones, hospital solutions, metabolism, musculoskeletal, respiratory, other parasitology, and sensory organs.
Counterfeit Drug Detection Device Market Country Level Analysis
Counterfeit drug detection device market is analysed and market size insights and trends are provided by country, product, modality, drug assessment, therapeutic assessment and end use as referenced above.
The countries covered in the counterfeit drug detection device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the counterfeit drug detection device market due to the high prevalence of healthcare infrastructure and manners adopted by market players against the rising duplicity of medicines and drugs.
The country section of the counterfeit drug detection device market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Counterfeit drug detection device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for counterfeit drug detection device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on counterfeit drug detection device market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Counterfeit Drug Detection Device Market Share Analysis
Counterfeit drug detection device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to counterfeit drug detection device market.
The major players covered in the counterfeit drug detection device market report are Advanced Systems Development, Inc., B&W Tek., Centice Corporation, Consumer Physics, Global Pharma HealthCare Ltd., Olympus Corporation, PharmaSecure Inc., RIGAKU CORPORATION, Sproxil, Stratio, Inc., Thermo Fisher Scientific Inc., TSI Group Inc., Veripad among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Counterfeit Drug Detection Device Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.